Difference between revisions of "Team:British Columbia/Description"

(Blanked the page)
Line 1: Line 1:
 +
{{British_Columbia/Navbar}}
  
 +
<html>
 +
<head>
 +
 +
  <meta charset="utf-8">
 +
  <meta name="viewport" content="width=device-width, initial-scale=1">
 +
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Josefin+Sans:300">
 +
 +
  <style>
 +
 +
h4{
 +
    font-family: Josefin Sans;
 +
    color: #4a857e;
 +
    font-size: 25pt;
 +
  letter-spacing: -1px;
 +
    -webkit-text-stroke: 1px;
 +
margin-left:100px;
 +
margin-bottom:1px;
 +
  }
 +
 +
p {
 +
    font-family: Josefin Sans !important;
 +
    color: black;
 +
    font-size: 15pt !important;
 +
letter-spacing: -1px;
 +
margin-top: 10px;
 +
    margin-left: 110px !important;
 +
    line-height: 25px !important;
 +
  }
 +
 +
.row {
 +
    margin-bottom: 10px;
 +
  }
 +
 +
.wrapper {
 +
    display: flex;
 +
    width: 100%;
 +
}
 +
 +
#in-content {
 +
  margin-left:20px;
 +
  max-width: 1000px;
 +
}
 +
 +
html {
 +
    height: 100% !important;
 +
}
 +
 +
 +
  </style>
 +
 +
</head>
 +
<body>
 +
 
 +
    <!-- page content -->
 +
    <div id="in-content">
 +
      <div class="container">
 +
        <div class = "row">
 +
    <img src="https://static.igem.org/mediawiki/2018/4/40/T--British_Columbia--overview-hdg.png"  style="height:28px; margin-top:35px;margin-left:100px;">
 +
</div>
 +
        <div class = "row">
 +
          <p> Distributing metabolic pathways between microbial community members has shown significant potential for the large-scale production of complex, biologically-derived chemical products. Our goal is to address the challenge of regulating population dynamics in a synthetic microbial consortium, by improving the rate of production of naringenin and its pharmaceutically significant derivative, kaempferol, which has anti-cancer properties. This is done by distributing the synthesis of kaempferol between two E. coli strains and optimizing their relative proportions in co-culture. To optimize population dynamics for the production of kaempferol, we regulated the ratio of the two strains using GP2, a transcriptional inhibitor, under the control of a biosensor responsive to the pathway intermediate naringenin. This couples cell growth with the concentration of naringenin, allowing the co-culture to self-optimize based on pathway intermediate abundance. Using our system, we have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds. </p>

Revision as of 00:39, 17 October 2018

Distributing metabolic pathways between microbial community members has shown significant potential for the large-scale production of complex, biologically-derived chemical products. Our goal is to address the challenge of regulating population dynamics in a synthetic microbial consortium, by improving the rate of production of naringenin and its pharmaceutically significant derivative, kaempferol, which has anti-cancer properties. This is done by distributing the synthesis of kaempferol between two E. coli strains and optimizing their relative proportions in co-culture. To optimize population dynamics for the production of kaempferol, we regulated the ratio of the two strains using GP2, a transcriptional inhibitor, under the control of a biosensor responsive to the pathway intermediate naringenin. This couples cell growth with the concentration of naringenin, allowing the co-culture to self-optimize based on pathway intermediate abundance. Using our system, we have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.